Search

everythinglearnresearchcommunity

for

Search:↓

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Certain groups may need vitamin supplements to improve hair health and prevent other health problems.

European guidelines recommend regular eye and ear exams, skin care, vitamin D supplements, and cautious use of medications for managing congenital ichthyoses.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

The article explains the genetic causes and symptoms of various hair disorders and highlights the need for more research to find treatments.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document explains different types of hair loss, their causes, and treatments, and suggests future research areas.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Mood stabilizers can cause serious skin reactions; careful monitoring and immediate treatment are crucial.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Skin reactions to antidepressants are common but usually not serious and can be treated.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Hidradenitis suppurativa may be related to hormones and patients often have metabolic disorders; more research is needed to understand this connection.

Adrenal disorders can cause lasting brain and behavior issues in children.

Loss of sebaceous glands and inflammation may contribute to the development of scarring alopecia.

Menstrual disorders are common in adolescents and can be influenced by weight, activity, and health issues, requiring careful evaluation and more research for effective treatment.

Epilepsy and certain epilepsy drugs can lead to reproductive problems in women, but changing medication might improve these issues.

The document concludes that inherited epidermolysis bullosa is a challenging genetic condition requiring multidisciplinary care and new treatments.

Low testosterone and 5α-reductase inhibitors can harm men's metabolic and sexual health; testosterone therapy may help, but discussing 5α-RIs' side effects is important.

Testosterone therapy may slightly improve sexual function in postmenopausal women, but its long-term safety is unknown.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

The document concludes that lifestyle changes and medical treatments can significantly reduce symptoms of Hidradenitis Suppurativa, a chronic skin condition.

Some skin disorders might be linked to H. pylori infection, but more research is needed to confirm this.

Acitretin is effective for severe psoriasis and can be used long-term due to no immunosuppression, but must be carefully monitored for side effects and is not for pregnant women.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Men with early-onset baldness have a higher chance of heart disease and clogged arteries.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.